1. Zeng, Xianyou, Wang, Hongquan, Yang, Jia, Hu, Jing. 2023. Micall2 Is Responsible for the Malignancy of Clear Cell Renal Cell Carcinoma. In Yonago acta medica, 66, 171-179. doi:10.33160/yam.2023.02.021. https://pubmed.ncbi.nlm.nih.gov/36811029/
2. Xia, Tianxiang, Ye, Fengwen, Zhao, Weizhen, Zhang, Yujie, Du, Jun. 2023. Comprehensive Analysis of MICALL2 Reveals Its Potential Roles in EGFR Stabilization and Ovarian Cancer Cell Invasion. In International journal of molecular sciences, 25, . doi:10.3390/ijms25010518. https://pubmed.ncbi.nlm.nih.gov/38203692/
3. Chen, Yingying, Song, Wei, Zhang, He, Ji, Xinping. 2023. MICALL2 participates in the regulation of epithelial-mesenchymal transition in alveolar epithelial cells - Potential roles in pulmonary fibrosis. In Archives of biochemistry and biophysics, 747, 109730. doi:10.1016/j.abb.2023.109730. https://pubmed.ncbi.nlm.nih.gov/37690696/
4. Xu, Xiaoyan, Qi, Jiaqian, Yang, Jingyi, Yang, Meng, Han, Yue. 2022. Up-Regulation of TRIM32 Associated With the Poor Prognosis of Acute Myeloid Leukemia by Integrated Bioinformatics Analysis With External Validation. In Frontiers in oncology, 12, 848395. doi:10.3389/fonc.2022.848395. https://pubmed.ncbi.nlm.nih.gov/35756612/
智鼠故事 
